BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8774418)

  • 21. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
    Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M
    J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.
    Schmidt C; Gerlach N; Peter C; Gherib K; Lange K; Friede T; Zerr I
    J Alzheimers Dis; 2015; 43(4):1229-36. PubMed ID: 25125466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.
    Zhou Z; Relkin N; Ghiso J; Smith JD; Gandy S
    Mol Med; 2002 Jul; 8(7):376-81. PubMed ID: 12393935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ;
    J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Talwar P; Sinha J; Grover S; Agarwal R; Kushwaha S; Srivastava MV; Kukreti R
    J Neurol Sci; 2016 Jan; 360():179-87. PubMed ID: 26723997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
    Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
    Neurosci Lett; 1996 Jul; 212(2):91-4. PubMed ID: 8832646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    Niemantsverdriet E; Goossens J; Struyfs H; Martin JJ; Goeman J; De Deyn PP; Vanderstichele H; Engelborghs S
    J Alzheimers Dis; 2016; 51(1):97-106. PubMed ID: 26836187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study.
    Wolters FJ; Koudstaal PJ; Hofman A; van Duijn CM; Ikram MA
    Neurosci Lett; 2016 Mar; 617():139-42. PubMed ID: 26876448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes of CSF biomarkers in Alzheimer's disease.
    Seppälä TT; Koivisto AM; Hartikainen P; Helisalmi S; Soininen H; Herukka SK
    J Alzheimers Dis; 2011; 25(4):583-94. PubMed ID: 21460434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.
    Slooter AJ; de Knijff P; Hofman A; Cruts M; Breteler MM; Van Broeckhoven C; Havekes LM; van Duijn CM
    Neurosci Lett; 1998 May; 248(1):21-4. PubMed ID: 9665654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.
    Motter R; Vigo-Pelfrey C; Kholodenko D; Barbour R; Johnson-Wood K; Galasko D; Chang L; Miller B; Clark C; Green R
    Ann Neurol; 1995 Oct; 38(4):643-8. PubMed ID: 7574461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms.
    Fania C; Arosio B; Capitanio D; Torretta E; Gussago C; Ferri E; Mari D; Gelfi C
    PLoS One; 2017; 12(6):e0179280. PubMed ID: 28628634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
    Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
    Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
    Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
    Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.